Mydecine Innovations Group Inc. (OTCMKTS:MYCOF – Get Rating) shares shot up 2.2% during trading on Tuesday . The company traded as high as $0.47 and last traded at $0.47. 1,467 shares traded hands during mid-day trading, a decline of 84% from the average session volume of 9,398 shares. The stock had previously closed at $0.46.
Mydecine Innovations Group Stock Up 2.2 %
The business has a fifty day moving average of $0.44 and a 200 day moving average of $0.52.
About Mydecine Innovations Group
Mydecine Innovations Group Inc, a biotech and life sciences company, engages in the development and commercialization of drugs for treating mental health problems. It develops therapies for veterans, emergency medical service providers, post-traumatic stress disorder, and front-line workers; and operates Mindleap, a digital telehealth platform that provides access to mental health services, as well as psychedelic integration services, including psychedelic aftercare and wellness services.
- Get a free copy of the StockNews.com research report on Mydecine Innovations Group (MYCOF)
- Qualcomm Gets a Boost from Analysts, but is it Time to Buy?
- EVgo Stock is Charged Up to Ride the EV Adoption Wave
- High-Yield, Deep-Value Verizon Puts In A Bottom
- Should You Bet Against The Nasdaq 100 With This Inverse ETF?
- Can Coty Stock Emerge in 2023 With Upside
Receive News & Ratings for Mydecine Innovations Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mydecine Innovations Group and related companies with MarketBeat.com's FREE daily email newsletter.